Live Longer. It’s Possible.
VYNDAMAX® (tafamidis) is the first and only, once-daily, single-capsule treatment for both the wild-type and hereditary forms of transthyretin amyloid cardiomyopathy (ATTR-CM), a rare and serious condition.
Learn about the VYNDAMAX Co-pay Savings Program
Use this fun and educational experience to learn about various topics related to ATTR-CM and VYNDAMAX.
Choose a topic to start
About ATTR-CM
Why VYNDAMAX?
Taking VYNDAMAX
Support & Resources
Skip & view matches
Stan’s VYNDAMAX journey
Stan’s VYNDAMAX journey
Hear from Stan, a real patient currently taking VYNDAMAX. Explore the site to find videos and quotes from Stan as he discusses his diagnosis journey, experience on treatment, and more.
Get to the heart of what to know about ATTR-CM and VYNDAMAX
